Cvs Health

CVS Healthcare & Pharma 4/10 Medium Risk
4/10
— 4 → 4 over 7 weeks
Sector avg: 2.8/10

Cvs Health has $63.7B in scheduled debt maturities. CVS shows thin interest coverage of 1.8x. DebtCanary scores CVS at 4/10, indicating moderate refinancing pressure.

Maturity Schedule

Year 1 $4.0B Year 2 $3.4B Year 3 $5.0B Year 4 $3.8B Year 5 $4.3B Beyond 5 $43.3B
Period Amount Due % of Total
Year 1 (0-12 months) $4.0B 6.3%
Year 2 (12-24 months) $3.4B 5.3%
Year 3 (24-36 months) $5.0B 7.9%
Year 4 (36-48 months) $3.8B 5.9%
Year 5 (48-60 months) $4.3B 6.7%
Beyond 5 Years $43.3B 68.0%
Total Scheduled Maturities $63.7B 100.0%

Key Metrics

Total Long-Term Debt
N/A
Near-Term (12mo)
$4.0B
Interest Coverage
1.8x
Debt/Equity
0.85
Cash Coverage
2.11x
Operating Income
$4.7B
EBITDA
$9.3B
Debt / EBITDA
6.9x
EBITDA / Interest
3.5x

Score Components

Component Value Weight
Near-Term Maturity Concentration 6.3% 30%
Interest Coverage Ratio 1.8x 25%
Debt-to-Equity Ratio 0.85 25%
Cash Coverage of Near-Term Debt 2.11x 20%

Recent SEC Filings

Material disclosures from Cvs Health's most recent EDGAR filings. 8-K item labels indicate the type of event reported.

Date Form Details
2026-04-03 DEFA14A Additional proxy materials
2026-04-03 DEF 14A Proxy statement
2026-03-19 8-K Officer / Director Change
2026-02-10 10-K Annual report
2026-02-10 8-K Earnings Results
2025-12-09 8-K Reg FD Disclosure
2025-11-20 8-K Other Events
2025-10-29 10-Q Quarterly report

Related Companies

Data Source: Financial data sourced from SEC EDGAR XBRL filings (10-K annual reports). Fiscal period end: 2025-12-31. Filing date: 2026-02-10. Data last fetched: 2026-04-30. Maturity schedules reflect the company's most recently reported debt repayment obligations. Data quality: Complete.
View SEC EDGAR filings for Cvs Health →